Climb Bio to Present at Upcoming Investor Conferences

Rhea-AI Summary

Climb Bio (Nasdaq: CLYM) announced that its executive team will present at three investor conferences in Feb–Mar 2026: Guggenheim Emerging Outlook: Biotech Summit on Feb 12, Oppenheimer Healthcare Life Sciences on Feb 25, and Leerink Global Healthcare on Mar 9.

The presentations are fireside chats with live webcasts available via the company’s Investors & Media website; replays will be posted about two hours after each event and archived for at least 30 days.

Argus Feb 5 session

-7.92% close to close Open Argus

Details

News Market Reaction – CLYM

On Feb 5, the day this news came out, CLYM closed 7.92% below the previous close.

Data tracked by StockTitan Argus for the Feb 5 session.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

WELLESLEY HILLS, Mass., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM), a clinical stage biotechnology company developing therapeutics for patients with immune-mediated diseases, today announced that members of its executive team will participate in the upcoming conferences detailed below.

Guggenheim's Emerging Outlook: Biotech Summit
Format: Fireside Chat
Date: Thursday, February 12, 2026
Time: 3:00 – 3:25 p.m. ET

Oppenheimer 36^th Annual Healthcare Life Sciences Conference
Format: Fireside Chat
Date: Wednesday, February 25, 2026
Time: 1:20 – 1:50 p.m. ET

Leerink Global Healthcare Conference
Format: Fireside Chat
Date: Monday, March 9, 2026
Time: 2:20 – 2:50 p.m. ET

The live webcasts will be accessible via the “Investors & Media” section of the Climb Bio website. Webcast replays will be available on the Climb Bio website beginning approximately two hours after each webcast event and will be archived for at least 30 days.

About Climb Bio, Inc.
Climb Bio, Inc. is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. The Company’s pipeline includes, budoprutug, an anti-CD19 monoclonal antibody that has demonstrated B-cell depletion and has potential to treat a broad range of B-cell mediated diseases, and CLYM116, an anti-APRIL monoclonal antibody in development for IgA nephropathy. For more information, please visit climbbio.com. 

Investors and Media
Carlo Tanzi, Ph.D.
Kendall Investor Relations
ctanzi@kendallir.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Climb Bio (CLYM) present at the Guggenheim Emerging Outlook: Biotech Summit?

Climb Bio will present on Thursday, February 12, 2026 at 3:00 p.m. ET in a fireside chat. According to the company, the session runs 3:00–3:25 p.m. ET and will be available via a live webcast on the Investors & Media website.

How can investors watch Climb Bio (CLYM) presentations at the Oppenheimer and Leerink conferences?

Investors can watch live webcasts via the Climb Bio Investors & Media webpage for each event. According to the company, replays are posted about two hours after each webcast and archived for at least 30 days.

What are the dates and times for Climb Bio (CLYM) presentations at the Oppenheimer and Leerink conferences?

Climb Bio will present at Oppenheimer on Wednesday, February 25, 2026 at 1:20 p.m. ET and at Leerink on Monday, March 9, 2026 at 2:20 p.m. ET. According to the company, each presentation is a fireside chat of roughly 30 minutes.

Will Climb Bio (CLYM) provide replays of its conference webcasts and for how long?

Yes. Replays will be available approximately two hours after each webcast and archived for at least 30 days. According to the company, replay links will be posted on the Investors & Media section of its website.

What topics will Climb Bio's (CLYM) executive team cover during the investor conference fireside chats?

The announcement states executives will participate in fireside chats but does not list specific topics. According to the company, the sessions are investor-focused presentations accessible via webcast, likely covering recent developments and corporate outlook.